Physician Payment Sunshine Act Some answers, many questions

BMJ (Online)

Volumn 347, Issue 7919, 2013, Pages

  Merino, José G ^a  

^a BMJ   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; INDUSTRY; LAW; MEDICAL EDUCATION; PHYSICIAN; PHYSICIAN PAYMENT SUNSHINE ACT; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT;

CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; FEES AND CHARGES; GIFT GIVING; HUMANS; INTERPROFESSIONAL RELATIONS; PHYSICIANS; UNITED STATES;

EID: 84881424971     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f4828     Document Type: Editorial

References (8)

1. Campbell EG. Doctors and drug companies-scrutinizing influential relationships. N Engl J Med 2007;357:1796-7. (Pubitemid 350044799)
2. Agrawal S, Brennan N, Budetti P. The sunshine act-effects on physicians. N Engl J Med 2013;368:2054-7.
3. Campbell EG, Rao SR, DesRoches CM, Iezzoni LI, Vogeli C, Bolcic-Jankovic D, et al. Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med 2010;170:1820-6.
4. Chimonas S, Kassirer JP. No more free drug samples? PLoS Med 2009;6:e1000074.
5. Kesselheim AS, Robertson CT, Siri K, Batra P, Franklin JM. Distributions of industry payments to Massachusetts physicians. N Engl J Med 2013;368:2049-52.
6. Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA 2012;307:669-70.
7. Center for Medicare and Medicaid Services. Medicare, Medicaid, children's health insurance programs: transparency reports and reporting of physician ownership or investment interests. Fed Regist 2013;78:9457-528.
8. Jack A. Bring me sunshine: EU drug companies make payments to doctors public. BMJ 2013;347:f4342.